Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-30 Option Award |
2024-07-02 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
91,396,000 | $0 | 3,502,891,500 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 4:30 pm |
N/A 2034-06-28 |
Akari Therapeutics Plc | AKTX | Hashad Mohamed Wa'el Ahmed Director |
5,000,000 | $0 | 5,000,000 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 4:30 pm |
N/A 2034-06-28 |
Akari Therapeutics Plc | AKTX | WILLIAMS DONALD A Director |
5,000,000 | $0 | 5,000,000 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 4:30 pm |
N/A 2034-06-28 |
Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director |
10,000,000 | $0 | 10,000,000 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:45 pm |
2024-05-31 2027-05-31 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
1,326,258,000 | $0.0009 | 4,737,753,500 (Indirect) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:45 pm |
2024-05-31 2027-05-31 |
Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director |
1,326,258,000 | $0.0009 | 5,823,572,800 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:46 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | DICICCO WENDY F Interim CFO |
158,473,915 | $0 | 158,473,915 (Direct) |
View |
| 2024-04-26 Option Award |
2024-04-30 9:45 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer |
479,569,892 | $0 | 1,018,027,792 (Direct) |
View |
Ownership |
2024-01-02 8:06 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer |
0 | $0 | 928,545,300 (Direct) |
View |
Ownership |
2024-01-02 8:00 pm |
2024-07-17 2033-07-17 |
Akari Therapeutics Plc | AKTX | DICICCO WENDY F Interim CFO |
0 | $0 | 5,000,000 (Direct) |
View |
Ownership |
2024-01-02 7:56 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
0 | $0 | 2,612,011,500 (Indirect) |
View |
Ownership |
2024-01-02 7:49 pm |
N/A 2033-06-30 |
Akari Therapeutics Plc | AKTX | Hashad Mohamed Wa'el Ahmed Director |
0 | $0 | 5,000,000 (Direct) |
View |
Ownership |
2024-01-02 6:58 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director |
0 | $0 | 3,494,957,900 (Direct) |
View |
Ownership |
2024-01-02 6:41 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Grissinger Michael Director |
0 | $0 | 36,500,000 (Direct) |
View |
Ownership |
2024-01-02 6:35 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | WILLIAMS DONALD A Director |
0 | $0 | 39,850,000 (Direct) |
View |